Company Profile

Year Established : 2004
Main Competitive Advantages : International Approvals/Standards,Experienced R&D Staff,Contract Manufacturing (CRO,CMO),Quality Service
Other Competitive Advantages : AAALAC Animal facility; GLP REGULATIONS; Integrated service; High qulity scientific staff; Three party risk sharing;
Patents and Copyrights : When we co-operate with clients, all the results, data, and patents will belong to our clinets. We never asked been invlolved in.

From its inception in 2004, Shanghai Medicilon Inc. (STAR Market,
stock code: 688202.SH) has been committed to providing
comprehensive research and development (R&D) services to
biopharmaceutical companies, research institutions, and any
organizations working in the preclinical space, with the primary
objective of supporting and accelerating pharmaceutical,
biopharmaceutical and medical device R&D worldwide.

Certificates/Standards
PharmaSources Customer Service